Results 1 to 10 of about 14,134 (231)

Topical Crisaborole for the Treatment of Recalcitrant Palmoplantar Pustulosis: A Case Series [PDF]

Dermatology and Therapy
Palmoplantar pustulosis (PPP) is a chronic, relapsing disease with sterile pustules involving the palms and soles. The pathogenesis of PPP remains unclear and there is currently no standard treatment.
Yen-Yi Sung, Tsen-Fang Tsai
doaj   +3 more sources

Case Report: Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab [PDF]

Frontiers in Immunology
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease mainly manifested as skin and osteoarticular lesions.
Luxia Chen, Qichang Liang, Sijia Chen, Hao Cheng   +3 more
doaj   +3 more sources

Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib [PDF]

Frontiers in Immunology
Palmoplantar Pustulosis (PPP) is a rare chronic skin disorder characterized by recurrent sterile pustules on palms and soles, leading to significant pain and functional impairment. Treatments include topical medications, phototherapy, systemic treatments,
Boyun Yang, Hanxiao Yu, Wo Yao, Huiying Wang   +3 more
doaj   +3 more sources

JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review [PDF]

Drugs in Context
Background: Palmoplantar pustulosis (PPP) is a chronic, relapsing skin condition characterized by sterile, pruritic pustules on erythematous, thickened skin of the palms and soles.
Beatriz Henriques dos Santos, João Domingues, Marco Sousa, Tiago Torres   +3 more
doaj   +3 more sources

Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients [PDF]

Frontiers in Medicine
BackgroundUpadacitinib, a specific JAK1 inhibitor, has minimal effect on other JAK subtypes. It influences the inflammatory process in various ways. Upadacitinib has been approved for conditions such as rheumatoid arthritis, psoriatic arthritis, atopic ...
Na Du, Jingyi Yang, Yiwen Zhang, Xinyan Lv, Lei Cao, Lei Cao, Lei Cao, Wei Min   +7 more
doaj   +3 more sources

Extra-Palmoplantar Lesions of Palmoplantar Pustulosis: Underrecognized but Important Manifestation

Indian Journal of Dermatology
Background: Patients with palmoplantar pustulosis (PPP) rarely develop scaly erythematous and/or pustular lesions on sites other than the palms and soles, such as the dorsa of the feet, lower legs, knees, elbows, buttocks and trunk.
Toshiyuki Yamamoto
doaj   +3 more sources

Short-Term Relief with Upadacitinib: A Case Report of Palmoplantar Pustulosis in a Pediatric Patient [PDF]

Clinical, Cosmetic and Investigational Dermatology
Qinchen Gu,1,2 Chen Zhang,3 Zhimin Lin,4 Yiting Fu,5 Chen Li,6,7 Zhenhua Ying2,8,9 1The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Zhejiang, 310014, People’s Republic of China; 2Department of Rheumatology and Immunology ...
Gu Q, Zhang C, Lin Z, Fu Y, Li C, Ying Z
doaj   +3 more sources

Apremilast is a potentially useful treatment for severe palmoplantar pustulosis with extra‐palmoplantar symptoms [PDF]

Skin Health and Disease
Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disorder affecting the palms and soles. In rare cases, severe patients develop acute extra‐palmoplantar lesions often accompanied by arthralgia.
Ayano Fukushima‐Nomura, Saeko Takamiyagi, Risa Kakuta, Yoshihiro Ito, Ikuko Hirai, Junichi Umemoto, Hironari Hanaoka, Yuko Kaneko, Keiji Tanese   +8 more
doaj   +3 more sources

Comments about the comparative bulk RNA sequencing between palmoplantar pustulosis and dyshidrotic palmoplantar eczema [version 1; peer review: 2 approved] [PDF]

F1000Research
This correspondence discusses the recent findings by Straalen et al., highlighting molecular similarities and distinctions between palmoplantar pustulosis (PPP) and dyshidrotic palmoplantar eczema (DPE).
Masamoto Murakami, Jun Muto, Kazuki Yatsuzuka   +2 more
doaj   +3 more sources

Adalimumab-Induced Erythrodermic Psoriasis Associated with Alopecia in a Patient with Palmoplantar Pustulosis

Indian Journal of Dermatology
In recent years, with the increased usage of tumour necrosis factor (TNF) inhibitors, more side effects have been revealed. Paradoxical psoriasis, including psoriasis vulgaris, palmoplantar pustulosis, scalp psoriasis and their combinations, is a common ...
Ying Wang, Yong Cui, Zhancai Zheng
doaj   +3 more sources